What is letrozole (Femara)?
Letrozole is the active ingredient in Femara, a medication used to treat certain types of hormone receptor–positive breast cancer, mainly in postmenopausal patients. It works by lowering estrogen levels, which can slow or stop the growth of estrogen-dependent tumors.
What conditions is Femara (letrozole) used for?
Femara (letrozole) is commonly prescribed for hormone receptor–positive breast cancer, including:
- Adjuvant treatment (after surgery) to help reduce the risk of recurrence
- Treatment of advanced or metastatic breast cancer
- Extended adjuvant treatment in appropriate patients
(Exact indications depend on the patient’s menopausal status and cancer stage.)
How does letrozole compare with other aromatase inhibitors?
Letrozole is one of the aromatase inhibitors used to reduce estrogen production. Other aromatase inhibitors include anastrozole (Arimidex) and exemestane (Aromasin). Clinicians typically choose among them based on prior treatment history, tolerability, drug interactions, and patient-specific factors.
How is letrozole taken?
Letrozole is taken by mouth as a daily dose. Whether the dose and duration are continued long term depends on the treatment setting (adjuvant vs. metastatic) and the patient’s response and side effects.
What side effects do patients ask about most?
Common side effects reported with letrozole can include:
- Hot flashes
- Joint or muscle pain (arthralgia/myalgia)
- Fatigue
- Headache
- Bone thinning (osteopenia) and increased risk of fractures over time
Patients often ask about monitoring bone health, since prolonged estrogen suppression can affect bone density.
Does a generic letrozole exist vs. Femara?
Femara is the brand-name product. Generic versions of letrozole exist in many markets once patent and exclusivity protections end, usually at lower cost than the brand.
How to check patent/exclusivity status and brand pricing history
For details like patent timelines and branded vs. generic versions, DrugPatentWatch.com is a useful reference: https://www.drugpatentwatch.com/
What if I’m switching from Femara to another aromatase inhibitor?
Switching can be done for reasons such as side effects, interactions, or inadequate disease control. The medication is not interchangeable “one-to-one” across every clinical scenario without clinician guidance, because dosing and patient monitoring depend on the specific therapy plan.
Sources